Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death by Katchanov, J. et al.
Mild Cerebral Ischemia Induces Loss of Cyclin-Dependent Kinase
Inhibitors and Activation of Cell Cycle Machinery before Delayed
Neuronal Cell Death
Juri Katchanov,1 Christoph Harms,1,2 Karen Gertz,1 Ludger Hauck,3 Christian Waeber,4 Lorenz Hirt,4
Josef Priller,1 Ru¨diger von Harsdorf,3 Wolfgang Bru¨ck,6 Heide Ho¨rtnagl,2 Ulrich Dirnagl,1 Pradeep G. Bhide,5
and Matthias Endres1
1Experimental Neurology, Department of Neurology, and 2Institute of Pharmacology and Toxicology, Charite´, Humboldt-
University of Berlin, D-10098 Berlin, Germany, 3Max-Delbru¨ck-Center fu¨r Molecular Medicine and Franz Volhard Clinic,
D-13125 Berlin, Germany, 4Stroke and Neurovascular Regulation Laboratory, and 5Developmental Neurobiology,
Massachusetts General Hospital, Harvard Medical School, Charlestown, 02129 Massachusetts, and 6Department of
Neuropathology, Charite´, Virchow Hospital, Humboldt-University of Berlin, D-13353 Berlin, Germany
After mild ischemic insults, many neurons undergo delayed
neuronal death. Aberrant activation of the cell cycle machinery
is thought to contribute to apoptosis in various conditions
including ischemia. We demonstrate that loss of endogenous
cyclin-dependent kinase (Cdk) inhibitor p16INK4a is an early and
reliable indicator of delayed neuronal death in striatal neurons
after mild cerebral ischemia in vivo. Loss of p27Kip1, another
Cdk inhibitor, precedes cell death in neocortical neurons sub-
jected to oxygen–glucose deprivation in vitro. The loss of Cdk
inhibitors is followed by upregulation of cyclin D1, activation of
Cdk2, and subsequent cytoskeletal disintegration. Most neu-
rons undergo cell death before entering S-phase, albeit a small
number (;1%) do progress to the S-phase before their death.
Treatment with Cdk inhibitors significantly reduces cell death in
vitro. These results show that alteration of cell cycle regulatory
mechanisms is a prelude to delayed neuronal death in focal
cerebral ischemia and that pharmacological interventions
aimed at neuroprotection may be usefully directed at cell cycle
regulatory mechanisms.
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Neurons enter and remain in a terminally differentiated or “rest-
ing” state after final cell division. If the control of the resting state
breaks down, neurons may reenter the cell cycle, a process that is
presumably lethal (Lee et al., 1992; Herrup and Busser, 1995; Gill
and Windebank, 1998). Thus, aberrant activation of the cell cycle
machinery is thought to cause apoptosis in postmitotic neurons
after various insults, including cerebral ischemia and Alzheimer’s
disease (Busser et al., 1998; Osuga et al., 2000; Sakurai et al.,
2000). Increases in cyclin D1 and cyclin-dependent kinase (Cdk)
4 expression occur after focal ischemia in mice and rats (Li et al.,
1997), in global ischemia in rats (Timsit et al., 1999), and in a
rabbit spinal cord ischemia model (Sakurai et al., 2000). In these
models the induction of cyclin D1 occurs in neurons either before
nuclear condensation and the appearance of chromosomal DNA
fragmentation (Timsit et al., 1999; Osuga et al., 2000) or after the
appearance of an apoptotic phenotype (Gue´gan et al., 1997).
Neuronally differentiated PC12 cells, sympathetic neurons, and
primary neuronal cells in culture upregulate cell cycle proteins
before their apoptotic death when DNA damage occurs or when
trophic support is withdrawn (Farinelli and Greene, 1996; Park et
al., 1996, 1997a,b, 1998; Padmanabhan et al., 1999).
On the other hand, expression of cell cycle markers after
ischemia might be a sign of potentially beneficial mechanisms.
Recovery from ischemic damage may recapitulate ontogeny, and
the expression of developmental proteins in the penumbra zone
to some degree may indicate active reconditioning that could
promote cell survival (Li et al., 1997, 1998; Cramer and Chopp,
2000).
The aim of the present study was to define the temporal and
spatial relationship between expression of cell cycle proteins
including cyclin D1, Cdk2, Cdk4, the endogenous Cdk inhibitors
p16INK4a and p27Kip1, and delayed neuronal death after mild
focal cerebral ischemia in mice (Endres et al., 1998b). We also
sought to determine the cell cycle event during which neuronal
death is triggered to gain an understanding of the link between
cell cycle regulation and delayed neuronal death. We found that
loss of endogenous Cdk inhibitors is a likely trigger for reentry of
postmitotic neurons into the cell cycle. Neurons that survive the
ischemia do not show any loss of Cdk inhibitors.
MATERIALS AND METHODS
Animal experiments. All experimental procedures that were performed
on laboratory animals conformed to institutional guidelines for the care
and use of laboratory animals. 129/SvEvTacBr wild-type mice (18–22 gm;
Taconic Farms, Germantown, NY) were administered 1 mg z hr 21 z kg 21
bromodeoxyuridine (BrdU; Sigma, St. Louis, MO) via subcutaneously
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implanted osmotic mini-pumps (flow rate 1 ml /hr; Alzet, Cupertino,
CA). This dose is nontoxic (Gould et al., 1997; Liu et al., 1998; Kem-
permann et al., 1998). The administration of BrdU via osmotic mini-
pumps was at least as effective as a more established method of daily
intraperitoneal injections (50 mg/kg body weight) as determined by
comparing the number of BrdU-positive cells using the two protocols
(data not shown).
Ischemia model. Mice were anesthetized for induction with 1.5%
halothane and maintained in 1.0% halothane in 70% N2O and 30% O2
using a vaporizer. Cerebral ischemia was induced with a 8.0 nylon
monofilament coated with a silicone resin/hardener mixture (Xantopren
M Mucosa and Activator NF Optosil Xantopren; Haereus Kulzer) as
described previously (Endres et al., 1998a,b, 1999, 2000). The filament
was introduced into the left internal carotid artery up to the anterior
cerebral artery. Thereby the middle cerebral artery and anterior choroi-
dal arteries were occluded. Filaments were withdrawn after 30 min of
ischemia to allow reperfusion. Regional cerebral blood flow measured
using laser-Doppler-flowmetry (Perimed, Jarfa¨lla, Sweden) fell to ,20%
during ischemia and returned to ;100% within 5 min after reperfusion
in either group ( p . 0.05). Core temperature during the experiment was
maintained at 36.5°C 6 0.5°C with a feedback temperature control unit.
Primary neuronal cell culture. Primary neuronal cultures of cerebral
cortex were obtained from E17 Wistar rats (Bundesinstitut fu¨r gesundheitli-
chen Verbraucherschutz und Veterina¨rmedizin, Berlin, Germany). Cul-
tures were prepared according to Brewer (1995) with some modifications as
described previously (Bruer et al., 1997; Lautenschlager et al., 2000). Whole
cerebral cortices were dissected, incubated for 15 min in trypsin/EDTA
(0.05/0.02% w/v in PBS) at 36.5°C, rinsed twice with PBS and once with
dissociation medium (modified Eagle’s medium with 10% fetal calf serum,
10 mM HEPES, 44 mM glucose, 100 U penicillin 1 streptomycin/ml, 2 mM
L-glutamine, 100 IE insulin/l), dissociated by Pasteur pipette in dissociation
medium, pelleted by centrifugation (at 210 3 g for 2 min at 21°C), redis-
sociated in starter medium (neurobasal medium with supplement B27, 100
U penicillin 1 streptomycin/ml, 0.5 mM L-glutamine, 25 mM glutamate), and
plated in 24-well plates at a density of 200,000 cells/cm 2. Wells were
pretreated by incubation with poly-L-lysine (0.5% w/v in PBS) at room
temperature for 1 hr, then rinsed with PBS, followed by incubation with
coating medium (dissociation medium with 0.03‰ w/v collagen G) for 1 hr
at 37°C, then rinsed twice with PBS, before cells were seeded in starter
medium. Cultures were kept at 36.5°C and 5% CO2 and were fed with
cultivating medium (starter medium without glutamate) by replacing half of
the medium twice a week beginning from the fourth day in vitro (DIV). By
choosing a serum-free culture condition, we were able to maintain cultures
with a very low percentage of glia (Lautenschlager et al., 2000). Neurobasal
medium and supplement B27 were obtained from Life Technologies
(Eggenstein, Germany); modified Eagle’s medium, PBS, HEPES buffer
trypsin/EDTA, penicillin/streptomycin, L-glutamine, collagen G, and poly-
L-lysine were from Biochrom (Berlin, Germany), and multi-well plates were
from Falcon (Franklin Lakes, NJ).
Oxygen–glucose deprivation. Serum-free primary neuronal cultures
were treated after 10–14 DIV. The condition of cells at various time
points after treatment was determined morphologically by phase-contrast
microscopy. Before oxygen–glucose deprivation (OGD), the medium was
removed from the cultures and preserved. Cultures were rinsed twice
with PBS, then subjected to OGD for 90 min in a balanced salt solution
at PO2 , 2 mmHg, followed by replacement of the preserved medium as
described previously (Bruer et al., 1997; Harms et al., 2000). For control
conditions, cells were placed in a balanced salt solution with 20 mM
D-glucose for 120 min in normoxic atmosphere with 5% CO2. Neuronal
injury was quantitatively assessed by the measurement of lactate dehy-
drogenase (LDH) at various time points in the medium (Koh and Choi,
1987). The enzyme standard for kinetic LDH test was obtained from
Sigma Chemie GmbH (Deisenhofen, Germany). Representative photo-
graphs were taken with phase-contrast microscopy 24 hr after OGD.
Olomoucine treatment protocol. The Cdk inhibitor olomoucine (Alexis,
Gru¨nberg, Germany), dissolved in DMSO (50 mM), was used at final
concentrations of 1, 10, and 100 mM in the medium. Olomoucine was
applied to cortical cell cultures 1 hr before and during OGD. The
vehicle-treated cultures received 0.2% DMSO.
Tissue preparation and immunocytochemistry. In the in vivo experi-
ments, the brains were perfusion fixed in 4% paraformaldehyde in 0.1 M
PBS, pH 7.4, and post-fixed in the same fixative overnight at 4°C. Coronal
40 mm sections were cut on a Vibratome (Technical Products, St. Louis,
MO). The sections were incubated in a blocking solution containing 10%
normal goat serum and 0.3% Triton X-100 for 30 min followed by the
primary antibodies [rabbit polyclonal anti-p16 INK4a, anti-p27 Kip1, anti-
cyclin D1 (Santa Cruz, Heidelberg, Germany); 1:250] overnight at 4°C.
After three washes with PBS, the sections were incubated in biotinylated
secondary antibody (goat anti-rabbit, 1:250; Vector Laboratories, Bur-
lingame, CA) for 90 min at room temperature and developed with Texas
Red-labeled streptavidin (1:200; Molecular Probes, Leiden, Holland).
Sections were washed in PBS and processed for double labeling with
neuronal markers as follows. The sections were incubated with antibodies
against neuronal markers, mouse monoclonal anti-MAP-2 (1:2000;
Roche, Grenzach-Wyhlen, Germany) or mouse monoclonal anti-NeuN
(1:100; Chemicon, Hofheim, Germany) overnight at room temperature.
This was followed by incubation in Alexa 488-conjugated goat anti-
mouse IgG (1:250; Molecular Probes) for 90 min at room temperature.
For terminal deoxynucleotidyl transferase-mediated biotinylated UTP
nick end labeling (TUNEL) histochemistry, unfixed brains were snap-
frozen in isopentane at 240°C. Coronal 10 mm sections were cut on a
cryostat (Microm, Heidelberg, Germany), thaw-mounted on glass slides,
and stored at 220°C. TUNEL was performed using a fluorescence
ApopTag Kit (Biogen, Heidelberg, Germany) according to the manufac-
turer’s instructions. For double labeling with TUNEL and cell-type
specific markers, sections were first incubated in blocking solution con-
taining 10% normal serum and 0.1% Triton in PBS and then incubated
overnight at 4°C with anti-NeuN (mouse monoclonal, 1:100; Chemicon),
anti-GFAP (astroglial marker, rabbit polyclonal, 1:500; Dako, Hamburg,
Germany), or anti-MAC-1 (microglial marker, rat monoclonal, 1:1000;
Serotec, Oxford, UK) antibodies, followed by incubation with corre-
sponding biotinylated secondary antibodies, and finally with Texas Red-
labeled streptavidin (Molecular Probes; 1:250). The sections were then
thoroughly rinsed in PBS and processed for TUNEL staining.
For BrdU and TUNEL double labeling, the sections were first pro-
cessed for TUNEL staining. Then, the DNA was hydrolyzed by 2N HCl
into single strands, and the sections were incubated with rat monoclonal
anti-BrdU antibody (1:500; Harlan, Borchen, Germany) overnight at 4°C
and reacted with biotinylated rabbit anti-rat IgG followed by Texas
Red-labeled streptavidin. For immunocytochemical analysis of cell cul-
tures, cells were seeded onto glass coverslips, fixed with freshly prepared
4% paraformaldehyde in PBS for 15 min, permeabilized with 0.3%
Triton X-100 in PBS, and exposed to blocking solution (PBS containing
10% goat serum and 1% bovine serum albumin) for 30 min at room
temperature. Cultures then were incubated with the rabbit polyclonal
antibodies to p16 INK4a, p27 Kip1, or cyclin D1 (1:100) for 1 hr at room
temperature and developed with Texas Red-labeled goat anti-rabbit IgG
(1:500) for 30 min at room temperature. After rinsing with PBS, the glass
coverslips were incubated with anti-NeuN (1:100) for 1 hr at room
temperature, followed by incubation in Alexa 488-conjugated goat anti-
mouse (1:500). For control studies, sections were treated the same way
except that TdT (for TUNEL studies) or primary antibodies (for immu-
noreactivity studies) were omitted, resulting in no visible staining.
Confocal laser scan microscopy. A Nikon Optiphot /Bio-Rad MRC 600
(Hempstead, UK) confocal laser scanning microscope equipped with an
argon/krypton laser was used. The images were acquired using CoMOS
software program (Version 7.0a, Bio-Rad) and imported into Adobe
Photoshop 5.0 (Adobe Systems, Mountain View, CA).
Cell counting protocols. To estimate the number of p16 INK4a-negative
MAP-2-positive neurons, four sections 80 mm apart at the level of
anterior commissure were chosen from each animal. Seven randomly
chosen nonoverlapping high-power fields (4003) from the striatum were
examined from each section (n 5 3 for each reperfusion time points at 9,
18, 48, and 72 hr as well as for sham-operated controls). All MAP-2-
positive neurons in each high-power field were counted, and the number
of MAP-2 positive that were p16 INK4 negative was recorded. TUNEL-
positive cells were counted in a single section at the same level in seven
randomly chosen, nonoverlapping high-power fields (n 5 3 for each time
point). The cells were classified as TUNEL positive only when they
showed strong nuclear signal with condensed nuclei with clumped chro-
matin without cytoplasmic staining (see Fig. 1 B, arrowheads). Colocal-
ization of TUNEL with BrdU was examined 72 hr after 30 min middle
cerebral artery occlusion (MCAo)/reperfusion (n 5 4) in three randomly
chosen sections at the level of anterior commissure, whereby 12 high-
power fields within each ischemic striatum were examined. The propor-
tion of TUNEL and BrdU double-labeled cells was calculated.
Electron microscopy. The mice were transcardially perfused with 0.1%
glutaraldehyde/2% paraformaldehyde. After overnight post-fixation, 60-
mm-thick Vibratome sections were processed for BrdU immunohisto-
chemistry using ABC kit (Vector) and DAB (Sigma) as a chromagen.
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The sections were post-fixed in 2.5% glutaraldehyde in PBS and 1%
osmium tetroxide, rinsed in 0.1 M sodium acetate, and stained with 2%
uranyl acetate for 1 hr. The sections were dehydrated in ethanol and
embedded in resin. Ultrathin sections were examined in a Zeiss EM10
electron microscope.
Immunoblots. Proteins were denatured by boiling in 30 ml sample
buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% w/v DTT, 2% w/v
SDS, and 0.01% w/v bromophenol blue) for 3 min. Samples (30 ml) were
subjected to 10% SDS-PAGE, and the dried gels were subjected to
autoradiography. Cells were lysed in 130 ml RIPA buffer (10 mM
Na2HPO4, pH 7.0, 300 mM NaCl, 0.1% w/v SDS, 1% v/v NP40, 1% w/v
Na-deoxycholate, 2 mM EDTA, 1 mM DTT, and protease/phosphatase
inhibitors as described) for 30 min on ice. Proteins were denatured by
boiling in 30 ml sample buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1%
w/v DTT, 2% w/v SDS, and 0.01% w/v bromophenol blue) for 3 min.
Samples (15 ml) were electrophoretically separated, transferred to poly-
vinylidene difluoride membranes and blocked, and primary antibodies
(0.2–1.0 mg/ml) were incubated overnight at 4°C on a rotary platform
with gentle agitation. They were subsequently probed with secondary
HRP-conjugated anti-mouse or anti-rabbit IgG antibodies (diluted
1:5000; Amersham Pharmacia Biotech, Braunschweig, Germany). Equal
loading was confirmed by resolving 20 mg total protein by SDS-PAGE
and probing with anti-actin antibody (1:2000). Detection was performed
using the enhanced chemiluminescence assay (Amersham). To provide
semiquantitative analysis of band intensity, band densitometry was de-
termined from scanned images of nonsaturated immunoblot films, using
Scion Image, version Beta 4.0.2 software (Scion Corporation, Frederick,
MD). To compare at least three different experiments, for each protein
and brain region, pixel intensities of the bands obtained in each exper-
iment were added and set as 100%. The individual band was calculated
as percentage of total signals.
Histone kinase assays. Anti-Cdk2 immunocomplexes were washed
twice in lysis buffer and once with ice-cold kinase buffer (50 mM Tris-
HCl, 10 mM MgCl2, 1.0 mM DTT) and resuspended in 50 ml kinase buffer
supplemented with 10 mg lysine-rich histone HIIIS (Sigma), 10 mCi
[g- 32P]ATP (111 MBq/mmol; NEN, Boston, MA). Control reactions
were run in parallel with the omission of antibody. After incubation for
60 min at 37 OC with continuous agitation, the reaction was terminated by
addition of 25 ml SDS sample buffer. Boiled samples (30 ml) were
separated by 15% SDS-PAGE and Coomassie stained for evaluation of
equal protein loading, and the amount of incorporated radioactive label
was quantified using a phosphorimager and TINA software (Raytest).
Statistical evaluation. Data are shown as mean 6 SEM. To avoid
possible variations of the cell cultures depending on the quality of
dissection and seeding procedures, data were pooled from at least three
representative experiments. For statistical analyses, one-way ANOVA
was followed by Tukey’s post hoc test. p , 0.05 was considered statisti-
cally significant.
RESULTS
Mild ischemia leads to delayed neuronal death
After 30 min MCA occlusion and reperfusion in 129/SV mice,
cell death was prominent in the striatum and spared the cortex
(Fig. 1A). TUNEL staining first appeared in the striatum at 18 hr,
increased by 36 hr, and peaked by 72 hr (Fig. 1B). When double
labeling for TUNEL and cell-type specific markers was per-
formed at the 72 hr time point, almost 100% of the TUNEL-
positive cells were also NeuN positive (Fig. 1C–E). However, not
any of the TUNEL-positive cells were GFAP positive (Fig. 1F–
H). Also, there was no MAC-1/TUNEL double labeling de-
tected, with the exception of some cells that most likely represent
engulfed nuclei of dead neurons (Fig. 1 I–K). Interestingly,
TUNEL and MAP-2 double labeling was not detected at 72 hr.
MAP-2, a neuron-specific cytoskeletal marker, was profoundly
downregulated in the ischemic region at the 72 hr time point (Fig.
1A); it is known to be extremely sensitive to ischemia (Li et al.,
1998; Endres et al., 1999). MAP-2-positive cells were TUNEL
negative and morphologically intact. These cells most likely rep-
resent neurons that survive the ischemic insult. We have reported
previously that only ;15% of the neurons, identified as such by
morphological criteria, survived at 72 hr, and this percentage did
not change significantly at 21 d (Endres et al., 1998b, 2000; Fink
et al., 1998).
Loss of p16INK4a and p27Kip1 after ischemia/reperfusion
We analyzed cellular localization of p16INK4a and p27Kip1, en-
dogenous Cdk inhibitors, in the striata of normal mice in vivo. We
detected strong immunoreactivity for the Cdk4 inhibitor
p16INK4a, a member of the INK4 family, in striatal neurons. In
fact, p16INK4a/NeuN double-labeling experiments confirmed that
all striatal neuronal nuclei expressed p16INK4a (Fig. 2A–C). No
staining was obtained with antibodies against p27Kip1, a member
of the CIP/KIP family that inhibits a wide range of Cdks (data
not shown). By contrast, cortical neurons in culture demonstrated
Figure 1. Selective neuronal death in the mouse striatum 72 hr after an
episode of 30 min MCAo and reperfusion. The low-power view of MAP-2
immunostaining indicates striatal lesion and cortical sparing (A). At
higher magnification (B), TUNEL-positive cells (arrowheads) show in
DAB staining condensed nuclei with clumped chromatin. Cells showing
weak diffuse DAB-positive cytoplasmic staining are not considered
TUNEL positive (arrow). Sections were double stained for TUNEL (C, F,
I ) and cell type-specific markers NeuN (D), GFAP (G), or MAC-1 ( J)
and examined in a confocal microscope. Cell-specific labeling was visu-
alized using antibodies conjugated with fluorescein (C, F, I: green) or
Texas Red (D, G, J: red). No double labeling was detected for TUNEL
and the astrocytic marker, GFAP (H ). Moreover, there was no double
labeling for TUNEL and the microglial marker, MAC-1 (K), with the
exception of some cells that most likely represent engulfed nuclei of dead
neurons (K, arrowhead). By contrast, most of the TUNEL-positive cells
were also immunoreactive for the neuronal marker NeuN (E), indicating
neuronal origin of the TUNEL-positive cells. Scale bars: A, 1 mm; B, 10
mm; C–K, 30 mm.
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nuclear staining for both p16INK4a and p27Kip1. p27Kip1/NeuN
double labeling confirmed strong nuclear expression of p27Kip1 in
cultured neurons (Fig. 2J–L), whereas p16INK4a immunoreactiv-
ity was weaker (data not shown). Expression of p16INK4a and
p27Kip1 protein was confirmed by immunoblot analysis.
After cerebral ischemia there was a profound and early down-
regulation of endogenous Cdk inhibitors. As early as 9 hr after 30
min MCAo/reperfusion, p16INK4a was downregulated in the
ischemic striatum (Fig. 2D–F). This early downregulation did not
simply reflect cell death or cytoskeletal disintegration because
p16INK4a-negative neurons were strongly MAP-2 positive and
intact by morphological criteria at 9 and 18 hr (Fig. 2G–I). We
analyzed the temporal and spatial relationship between p16INK4a
downregulation, MAP-2 staining, and markers of cell death. At 9
hr, when no TUNEL-positive cells were detected in the ischemic
striatum, 48.0 6 8.3% of all MAP-2-positive cells were p16INK4a
negative. Thus, some MAP-2-expressing, apparently intact neu-
rons downregulated p16INK4a well before TUNEL labeling be-
came apparent. Concomitant with the increase of TUNEL-
positive cells, the amount of p16-negative and morphologically
intact neurons decreased (23.3 6 1.8% at 18 hr vs 16.7 6 8.3% at
48 hr) (Fig. 3). At 72 hr all remaining morphologically intact
MAP-2-positive neurons were p16INK4a positive. Moreover,
TUNEL and p16INK4a double-labeled cells were not detected at
any time point. Thus, p16INK4a downregulation preceded MAP-2
downregulation and neuronal death.
Similar to the early downregulation of p16 INK4a in vivo,
p16 INK4a and p27 Kip1 were downregulated in cultured cortical
neurons as early as 2 hr after OGD, as shown by immunohis-
tochemistry (Fig. 2 M–O) and immunoblots (p16 INK4a: 44.9 6
9.9% decrease at 4 hr, p , 0.001; p27 Kip1: 34.6 6 9.0 and
57.2 6 6.5% decrease at 2 and 4 hr, p , 0.05 and p , 0.001,
respectively) (Fig. 4).
When our in vivo and in vitro data are taken together, endog-
enous Cdk inhibitors such as p16INK4a or p27Kip1 appear to be
reliable markers of neuronal survival and their loss a reliable
indicator of neuronal death after cerebral ischemia.
Cell cycle protein expression after ischemia/hypoxia
Next, we investigated the expression of the G1 phase cyclin, cyclin
D1, in striatal neurons in vivo after focal ischemia and in neocor-
tical neurons in vitro after OGD. We detected no cyclin D1
immunoreactivity in striatal neurons from sham-operated con-
trols (data not shown), whereas cortical neurons in control cul-
tures expressed cyclin D1 in the cytosol (Fig. 5A–C). Cyclin D1 is
thought to be inactive in the cytosol and requires nuclear trans-
location to activate Cdks (Yang and Kornbluth, 1999). Indeed,
Figure 2. Expression of p16 INK4a and p27 Kip1, endogenous inhibitors of
cyclin-dependent kinases, after 30 min MCAo and reperfusion in the
mouse striatum (A–I, p16 INK4a) and after OGD in rat primary cortical
neurons (J–O, p27 Kip1). Immunoreactivity for p16 INK4a/p27Kip1 was vi-
sualized with Texas Red (A, D, G, J, M: red), and neuronal marker NeuN
was visualized with Alexa 488 (B, E, H, K, N: green), with colocalization
resulting in a yellow color (C, F, I, L, O). Strong nuclear expression of
p16 INK4a was seen in all neurons in the normal (non-ischemic) striatum as
shown by double labeling with p16 INK4a and NeuN (A–C). p16 INK4a
immunoreactivity was lost in ischemic striatal neurons at 9 hr after
MCAo/reperfusion as shown by the appearance of NeuN-positive p16-
negative cells (D–F, arrowheads). Double labeling of p16 INK4a with the
ischemia-sensitive neuronal marker MAP-2 demonstrated that the loss of
p16 INK4a expression occurred in cytoarchitectonically intact neurons at 9
hr (G–I; arrowhead in I ). Strong nuclear p27 Kip1 immunoreactivity was
detected in all neurons in primary neuronal culture (J–L). Two hours
after OGD the majority of neurons downregulated p27 Kip1, as indicated
by arrowheads (M–O). Scale bars, 30 mm.
Figure 3. Time course of p16 INK4a downregulation and delayed neuro-
nal death after 30 min MCAo. A, The number of p16 INK4a-negative and
MAP-2 positive cells is presented as a percentage of all MAP-2-positive
cells at 9, 18, 48, and 72 hr after MCAo as well as in sham-operated,
control mice. In controls and at 72 hr after MCAo, all MAP-2-positive
cells were also p16 INK4a positive. B, The number of TUNEL-positive
cells per square millimeters was determined at the same time points as in
A. No TUNEL positivity was observed in sham-operated animals and at
9 hr after MCAo, whereas the maximum number of TUNEL-positive
cells was observed at 72 hr after MCAo; n 5 3–6. Data are mean values 6
SEM. *p , 0.05; ***p , 0.001.
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after cerebral ischemia in vivo and OGD in vitro, we detected
nuclear expression and an increase in immunoreactivity of cyclin
D1 (Fig. 5D–I). Z-series confocal images confirmed nuclear ex-
pression of cyclin D1 (Fig. 5J). Immunoblot analyses confirmed
the increase in cyclin D1 in vitro detected by immunohistochem-
istry (150.8 6 21.0% at 6 hr, p , 0.05) (Fig. 4). As expected, some
glial cells exhibited strong cyclin D1 immunoreactivity in vivo.
Cyclin D1 activates Cdk4, which in turn phosphorylates the
retinoblastoma protein in mid G1 phase, followed by the activa-
tion of Cdk2 around the G1–S transition. We performed histone
kinase assays to determine Cdk2 activity in cultured cortical
Figure 4. Immunoblots showing time-dependent changes of cell cycle-
related proteins in primary cortical neurons after 90 min oxygen–glucose
deprivation. Cell lysates (20 mg) were subjected to SDS-PAGE, and
membranes were probed with antibodies against p16 INK4a, p27 Kip1, and
cyclin D1 (0.2–1.0 mg/ml). Actin served as internal control. The experi-
ment was repeated three times; a representative experiment is shown. For
semiquantitative analysis, the intensity of each band was quantitated from
scanned images of nonsaturated immunoblot films using Scion Image
(Scion Corporation, Frederick, MD). The pixel intensity of the bands
obtained in each experiment was summed and set as 100%, and the
individual band was calculated as percentage of total signals. The graphs
show a significant downregulation of p27 Kip1 starting at 2 hr and of
p16 INK4a at 4 hr after OGD compared with controls. Cyclin D1 levels
were significantly upregulated at 6 hr and further increased at 48 hr. Mean
value 6 SEM. *p , 0.05; **p , 0.01; ***p , 0.001.
Figure 5. Cyclin D1 expression in primary cortical neurons in culture
after OGD (A–F ) and in striatal neurons of mice after MCAo/reperfu-
sion (G–I ). Immunoreactivity for cyclin D1 was visualized with Texas
Red (A, D, G; red), and neuronal marker NeuN was visualized with Alexa
488 (B, E, H; green). Double labeling for cyclin D1 and NeuN demon-
strates that cyclin D1 is expressed exclusively in the cytoplasm of cultured
neurons under control conditions (A–C). Two hours after OGD cyclin D1
is strongly upregulated, and its immunoreactivity translocates to the
nucleus (D–F, arrowhead). Confocal Z-series images (step 5 1 mm)
confirm the nuclear expression of cyclin D1 in OGD-treated neurons ( J).
Cyclin D1 is not expressed in normal striatal neurons (data not shown).
Forty-eight hours after MCAo/reperfusion, nuclear cyclin D1 immuno-
reactivity is detected in neurons in the ischemic striatum (G–I, arrow-
head). Scale bars: A–I, 30 mm.
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neurons after OGD to determine whether the molecular machin-
ery necessary for G1–S transition was being mobilized (Fig. 6).
Cdk2 activity increased at 12 hr (658.3 6 4.3% increase, p , 0.05)
and peaked at 24 hr (1171.0 6 137.5% increase, p , 0.01). When
cells were pretreated with olomoucine (1–100 mM), a synthetic
Cdk inhibitor, Cdk activation at 12 and 24 hr was completely
abolished (Fig. 6). Hence, we demonstrate that Cdks are acti-
vated in neurons after ischemia/hypoxia, and olomoucine admin-
istration effectively inhibits Cdk activation in this model. Immu-
noblot experiments showed that protein levels of Cdk4 and Cdk2
did not change significantly over time (data not shown).
Inhibition of Cdk activity protects from
oxygen–glucose deprivation
Olomoucine is a purine derivative that inhibits Cdks 1, 2, and
5 and ERK1/MAP-kinase and blocks G1–S-phase transition
(Vesely et al., 1994; Abraham et al., 1995). Cultured cortical
neurons were pretreated with olomoucine (1, 10, or 100 mM)
before OGD. Cell damage after OGD was determined by
quantif ying LDH release into the culture medium. Olo-
moucine pretreatment significantly protected neurons from
OGD and reduced LDH release at 24 hr (Fig. 7A). The
strongest protection was achieved with 10 mM concentration
(;75% reduction in LDH release; 41.5 6 7.6 vs 9.2 6 2.6 U/ml
medium; n 5 24 in three independent experiments; p 5 0.004).
The decrease in LDH release (Fig. 7A) correlated with higher
numbers of viable neurons at 72 hr as assessed by phase-
contrast microscopy (Fig. 7B–D). Thus, inhibition of Cdk ac-
tivity protects cultured cortical neurons against OGD.
Progression to S-phase is a rare event
We used BrdU as a marker for DNA synthesis (Nowakowski et
al., 1989) to determine whether downregulation of Cdk inhibitors
and upregulation of cyclin D1 caused striatal neurons to enter
S-phase after ischemic damage in vivo. After 30 min MCAo and
reperfusion, BrdU-positive cells first appeared in the ischemic
striatum at 36 hr. Their numbers increased at 48 and 72 hr. Most
of the BrdU-labeled cells had the morphological appearance of
microglia/macrophages and could be labeled with antibodies
against MAC-1. A small number of NeuN-labeled cells were
BrdU positive at 72 hr (,1%; data not shown). In fact, electron
microscopy confirmed that some BrdU-positive cells were indeed
neurons (Fig. 8A). A small fraction of TUNEL-positive cells was
BrdU positive (0.957 6 0.172% of all TUNEL-positive cells; 72
hr; n 5 4 animals), indicating that some of the TUNEL-positive
cells had entered S-phase (Fig. 8B–G). As demonstrated in Fig-
ure 1, virtually all TUNEL-positive cells are NeuN positive at 72
hr. Together, these data suggest that some neurons indeed en-
tered S-phase before their death.
We were not able to detect any mitotic figure, however, either
in vivo or in vitro, although the presence of mitotic figures has
been reported after a hypoxic insult in vitro (Bossenmeyer-Puorie´
et al., 1999). It appears that although some neurons enter S-phase,
they do not proceed beyond the G2–M checkpoint within 72 hr
after the insult.
DISCUSSION
We provide evidence that cell cycle protein expression is altered
in postmitotic neurons in response to focal cerebral ischemia. The
earliest event is the downregulation of the Cdk inhibitors
p16INK4a and p27Kip1 followed by upregulation and nuclear ex-
pression of cyclin D1 and activation of Cdks. We consider these
events as “attempts” at cell cycle reentry. Because none of the
neurons enters M-phase within the 72 hr period, we conclude that
Figure 6. Cdk2 activity increases in cortical neurons in culture after 90
min OGD. Cell lysates were immunoprecipitated with anti-Cdk2 anti-
body, and the resultant complexes were allowed to incubate with
[g-32P]ATP and histone HIIIS as substrate. In each lane, 30 mg protein
was separated. There was a clear increase in kinase activity at 12 and 24
hr after OGD as compared with control. This kinase activation at 12 and
24 hr was completely abolished when the cells were pretreated with 10 mM
olomoucine (olo) 1 hr before and during OGD. To estimate Cdk2
activity, the amount of incorporated radioactive label was quantified
using a phosphorimager and TINA software. The values of three
independent experiments are graphically represented as mean value 6
SEM. *p , 0.01; **p , 0.001 versus control.
Figure 7. The Cdk inhibitor olomoucine protects primary neuronal cul-
tures subjected to OGD. A, Quantitative assessment of neuronal injury by
measurement of LDH release 24 hr after OGD presented as the difference
between control cultures and cultures subjected to OGD. Olomoucine
treatment produced significant protection at 10 and 100 mM, whereas higher
concentrations were toxic to the cultures (data not shown). The results are
presented as the mean value 6 SEM from three independent experiments
performed in triplicate. *p , 0.05 and **p , 0.01 versus vehicle-pretreated
sister cultures exposed to OGD; one-way ANOVA followed by Tukey’s post
hoc test. B, Phase-contrast micrograph of primary cortical neurons in
culture. C, Twenty-four hours after 90 min OGD and pretreatment with
vehicle (0.02% DMSO). D, Cultures exposed to the same insult as in C but
pretreated with olomoucine (10 mM). Scale bar, 70 mm.
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these attempts fail. These findings show that neurons attempt cell
cycle reentry after cerebral ischemia, most likely because of loss
of endogenous Cdk inhibitors, and that the loss of Cdk inhibitors
is a preamble for neuronal death rather than for cell division or
survival, or both.
Loss of endogenous cell cycle inhibitors may be an
early trigger for cell cycle activation
P16INK4a and p27Kip1 induce cell cycle arrest by inhibiting Cdk
activity (Johnson and Walker, 1999; Vidal and Koff, 2000), and
they promote cell cycle exit during development (Zindy et al.,
1997; Watanabe et al., 1998). We show that virtually all neurons
in the striatum express p16INK4a and that all postmitotic neurons
in cortical cultures express p27Kip1 in the nucleus. Nuclear ex-
pression of p16INK4a in vivo and p27Kip1 in vitro, but not vice
versa, may relate to differences in cell maturation. The in vivo
studies were performed on 6-week-old mice, whereas the neurons
in vitro were obtained from embryonic day 17 rats and cultured for
up to 14 d. p27Kip1 is the predominant Cdk inhibitor and the only
Cdk inhibitor to decrease 5 hr after KCl withdrawal in primary
cultures of cerebellar granule neurons at 5–6 d in vitro (Padma-
nabhan et al., 1999). By contrast, increased levels of p16INK4a are
associated with cell senescence (Huschtscha and Reddel, 1999),
and its expression may relate to a more mature state.
After an ischemic insult, p16INK4a and p27Kip1 were pro-
foundly downregulated. We propose that the downregulation acts
as an early trigger of attempted cell cycle reentry and subsequent
neuronal death. The loss of p16INK4a is a specific event and not
related to general protein degradation, because at early time
points, p16INK4a-negative neurons are morphologically intact and
express MAP-2. Most neurons downregulate p16INK4a between 9
and 18 hr after ischemia (Figs. 3, 4). Later on, p16INK4a-negative
neurons undergo cytoskeletal disintegration and become
TUNEL positive, whereas virtually every neuron that maintains
high levels of p16INK4a remains viable at least for 72 hr. Hence,
p16INK4a may be a survival factor, and its early downregulation
may predict neuronal death. Similarly, Sindbis virus-induced ex-
pression of p16INK4a/p27 Kip1 protected sympathetic and cortical
neurons from death induced by DNA-damaging compounds
(Park et al., 1998).
Our in vitro evidence showed unequivocally that the loss of
p27Kip1 was paralleled by nuclear expression of cyclin D1, closely
followed by Cdk2 activation, which is thought to be crucial for
G1–S transition (Sherr, 1994). Some ischemic neurons progressed
to S-phase in our in vivo model (see below). These data are in
agreement with several studies on brain tumors showing that the
loss of endogenous Cdk inhibitors is sufficient to precipitate
uncontrolled cell proliferation (Nishikawa et al., 1995; Ueki et al.,
1996). Similarly, expression of Cdk inhibitors was investigated in
Alzheimer’s disease and in support of the hypothesis that an
aborted attempt to activate the cell cycle in terminally differen-
tiated neurons might be a critical event in the pathomechanism of
Alzheimer’s disease (Arendt et al., 1996, 1998; McShea et al.,
1997, 1999; Nagy et al., 1997).
Cell cycle protein expression and delayed
neuronal death
We demonstrate upregulation and, more importantly, nuclear
expression of cyclin D1 in neurons after ischemia/hypoxia, ex-
tending previous reports (Freeman et al., 1994; Kranenburg et al.,
1996; Li et al., 1997, 1998; McShea et al., 1997; Nagy et al., 1998;
Timsit et al., 1999). Nuclear expression of cyclin D1 was followed
by Cdk activation. Inhibition of Cdk activation protected neurons
from death, a finding that is in accordance with studies that
exposed cultured neurons to various insults, including DNA dam-
age, trophic factor deprivation, and b-amyloid toxicity (Park et
al., 1997a; Bossenmeyer-Puorie´ et al., 1999; Stefanis et al., 1999).
In preliminary experiments, we also detected Cdk4 expression in
Figure 8. TUNEL/BrdU double labeling. BrdU was administered via
subcutaneous osmotic mini-pumps in 129/SV mice (1 mg z hr 21 z kg 21
body weight). Mice were subjected to 30 min of MCAo and 72 hr
reperfusion. A, For electron microscopy studies, Vibratome sections of
ischemic striatum were immunostained for BrdU using DAB as a chroma-
gen. Electron micrograph shows a cell with numerous electron-dense
osmiophilic granules (large arrows) within the nucleus corresponding to
the BrdU labeling. The cell has a central nucleus with a prominent
nucleolus (small arrow) and multiple vesicles (arrowheads) in its cytoplasm
and lacks glial filaments, indicating that it is of neuronal origin. Original
magnification: 11,0003. TUNEL/BrdU double labeling was performed
on fresh-frozen cryosections (10 mm) using ApopTag Kit and rat mono-
clonal anti-BrdU antibody. TUNEL was visualized with fluorescein (B, E:
green), and Texas Red was used for BrdU immunoreactivity (C, F: red). Of
all TUNEL-positive cells, 0.957 6 0.172% stain positive for the S-phase
marker BrdU (n 5 4 animals). Z-series of confocal images through the
nucleus (1 mm steps) confirms the costaining for both markers (D, G:
yellow). Scale bar, 30 mm.
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striatal neurons in vivo. Although we did not study the effects of
olomoucine in vivo, a recent study convincingly demonstrated that
Cdk inhibitors protect neurons from death after focal cerebral
ischemia (Osuga et al., 2000).
The mechanisms that cause cell death after Cdk activation
have remained elusive. They may relate to release of cytochrome
c and activation of caspase 9 and eventually caspase-3 (Stefanis et
al., 1999). We have demonstrated previously that activation of
caspase 3 contributes to cell death after mild ischemia (Endres et
al., 1998b; Fink et al., 1998) and OGD (Harms et al., 2000), and
the time course of caspase activation is compatible with cell cycle
events reported in this study. Another possibility is that Cdk
activation might mediate cell death by converting p35 to neuro-
toxic p25 (Patrick et al., 1999)
S-phase progression after cerebral ischemia
The expression of cell cycle-related proteins after ischemia may
signify their function in the apoptotic machinery rather than in
the cell cycle (Heintz, 1993; Padmanabhan et al., 1999; Park et al.,
1998; Stefanis et al., 1999). To further analyze cell cycle progres-
sion, we used BrdU as S-phase marker (Nowakowski et al., 1989;
Takahashi et al., 1993; Gage et al., 1995). After ischemia some
cells were double labeled with TUNEL and BrdU in our in vivo
model. Because virtually all TUNEL cells were NeuN positive by
72 hr (Fig. 1), we postulate that the TUNEL and BrdU double-
labeled cells are neurons. Indeed, we identified BrdU-positive
cells as neurons by electron microscopy (Fig. 8A). Similarly,
TUNEL/BrdU double labeling was also used in previous studies
in the developing nervous system to demonstrate S-phase pro-
gression before apoptotic death (Thomaidou et al., 1997;
ElShamy et al., 1998). Reentry of neurons into S-phase before cell
death was a rare event: ;1% of the TUNEL-positive cells were
BrdU positive. Thus, the majority of neurons died before S-phase
after Cdk activation. Accordingly, in preliminary experiments we
did not detect any expression of cyclin A and cyclin B in ischemic
neurons, which are indicative of S–G2 and G2–M transition,
respectively. Another caveat may be that BrdU incorporation
indicated DNA repair rather than DNA synthesis. However, a
significant number of TUNEL-positive cells (i.e., .99% at 72 hr)
are not labeled with BrdU (which would be the case if BrdU were
the marker of DNA damage) (Thomaidou et al., 1997). Moreover,
other markers of proliferation such as cyclin D1 are expressed.
There is good evidence in the literature from both in vitro as well
as in vivo experiments that the concentration of BrdU used in this
study is not sensitive enough to detect DNA repair (Gobbel et al.,
1998; Parent et al., 1999; Palmer et al., 2000). Thus, we show that
a small number of neurons enter S-phase before undergoing
delayed cell death.
The fact that we were not able to identify mitotic figures argues
against the possibility that BrdU labeled-neurons were newly born
during the 72 hr period (Gu et al., 2000). Furthermore, it is
unlikely that 72 hr would be a sufficient interval for a progenitor
cell to give rise to a mature neuron (Kuhn et al., 1996; Palmer et
al., 2000). Moreover, we were not able to detect any obvious
migration of BrdU-positive cells from the subventricular zone of
neuronal progenitor cells to the ischemic striatum by 72 hr.
In conclusion, we show that endogenous Cdk inhibitors are
constitutively expressed in quiescent neurons but that they are
downregulated early after cerebral ischemia/hypoxia. We show
that the loss of Cdk inhibitors may be the trigger for cell destruc-
tion. The downstream events leading to delayed neuronal death
after Cdk activation remain to be determined.
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